{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:46:20Z","timestamp":1792449980255,"version":"4.5.0"},"reference-count":380,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R35-CA197743"],"award-info":[{"award-number":["R35-CA197743"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016394","name":"Harvard Medical School Ludwig Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016394","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001927","name":"Nile Albright Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001927","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01-CA261842"],"award-info":[{"award-number":["U01-CA261842"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-CA269672"],"award-info":[{"award-number":["R01-CA269672"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-CA259253"],"award-info":[{"award-number":["R01-CA259253"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01-CA224348"],"award-info":[{"award-number":["U01-CA224348"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-NS118929"],"award-info":[{"award-number":["R01-NS118929"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001767","name":"National Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.cell.2026.03.016","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:03:30Z","timestamp":1776351810000},"page":"2379-2415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Targeting angiogenesis: Lessons from 25 years of normalizing tumor vasculature"],"prefix":"10.1016","volume":"189","author":[{"given":"Sonu","family":"Subudhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7571-3548","authenticated-orcid":false,"given":"Rakesh K.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2026.03.016_bib1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.016_bib2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.016_bib3","first-page":"851","article-title":"Role Played by the Trauma in the Dissemination of Tumor Fragments by the Circulation. Tumor Studied: Brown-Pearce Rabbit Epithelioma","volume":"28","author":"Ide","year":"1939","journal-title":"Arch. Pathol."},{"key":"10.1016\/j.cell.2026.03.016_bib4","first-page":"13","article-title":"Microscopic Studies of the Early Growth of a Transplantable Melanoma of the Mouse, Using the Transparent-chamber Technique","volume":"4","author":"Algire","year":"1943","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.cell.2026.03.016_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jnci\/6.1.73","article-title":"Vasculae Reactions of Normal and Malignant Tissues in Vivo. I. Vascular Reactions of Mice to Wounds and to Normal and Neoplastic Transplants","volume":"6","author":"Algire","year":"1945","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.cell.2026.03.016_bib6","first-page":"111","article-title":"Tumor angiogenesis: transfilter diffusion studies in the hamster by the transparent chamber technique","volume":"41","author":"Greenblatt","year":"1968","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.cell.2026.03.016_bib7","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumor angiogenesis: therapeutic implications","volume":"285","author":"Folkman","year":"1971","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib8","article-title":"Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives","volume":"10","author":"Lee","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cell.2026.03.016_bib9","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0006-291X(89)92678-8","article-title":"Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells","volume":"161","author":"Ferrara","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cell.2026.03.016_bib10","first-page":"1829","article-title":"Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature","volume":"57","author":"Dark","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2026.03.016_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF01954881","article-title":"Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4","volume":"45","author":"Pettit","year":"1989","journal-title":"Experientia"},{"key":"10.1016\/j.cell.2026.03.016_bib12","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nm0901-987","article-title":"Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy","volume":"7","author":"Jain","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.03.016_bib14","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1200\/JCO.2012.46.3653","article-title":"Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers","volume":"31","author":"Jain","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cell.2026.03.016_bib15","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ccell.2014.10.006","article-title":"Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia","volume":"26","author":"Jain","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2026.03.016_bib16","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1152\/physrev.00038.2010","article-title":"Normalization of the vasculature for treatment of cancer and other diseases","volume":"91","author":"Goel","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cell.2026.03.016_bib17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","article-title":"Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges","volume":"15","author":"Fukumura","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cell.2026.03.016_bib18","first-page":"553","article-title":"Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases","volume":"6","author":"Winkler","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2026.03.016_bib19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nm988","article-title":"Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer","volume":"10","author":"Willett","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ccr.2006.11.021","article-title":"AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients","volume":"11","author":"Batchelor","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2026.03.016_bib21","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1158\/0008-5472.CAN-04-0074","article-title":"Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors","volume":"64","author":"Tong","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2026.03.016_bib22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1146\/annurev-physiol-020518-114700","article-title":"Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges","volume":"81","author":"Martin","year":"2019","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.cell.2026.03.016_bib23","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41586-024-07493-y","article-title":"Single-cell atlas of the human brain vasculature across development, adulthood and disease","volume":"632","author":"W\u00e4lchli","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.016_bib24","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.immuni.2025.02.022","article-title":"Single-cell atlas of endothelial and mural cells across primary and metastatic brain tumors","volume":"58","author":"Bejarano","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2026.03.016_bib184","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1126\/science.6823562","article-title":"Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid","volume":"219","author":"Senger","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.03.016_bib60","article-title":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cell.2026.03.016_bib362","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.devcel.2008.07.014","article-title":"VEGFR3: a new target for antiangiogenesis therapy?","volume":"15","author":"Padera","year":"2008","journal-title":"Dev. Cell"},{"key":"10.1016\/j.cell.2026.03.016_bib251","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1023\/A:1009018702832","article-title":"Binding and displacement of vascular endothelial growth factor (VEGF) by thrombospondin: effect on human microvascular endothelial cell proliferation and angiogenesis","volume":"3","author":"Gupta","year":"1999","journal-title":"Angiogenesis"},{"key":"10.1016\/j.cell.2026.03.016_bib363","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","article-title":"Endostatin: an endogenous inhibitor of angiogenesis and tumor growth","volume":"88","author":"O'Reilly","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.016_bib364","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0092-8674(94)90200-3","article-title":"Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma","volume":"79","author":"O'Reilly","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.016_bib328","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib365","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1517\/14712598.6.11.1237","article-title":"Ranibizumab: treatment in patients with neovascular age-related macular degeneration","volume":"6","author":"Pieramici","year":"2006","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.cell.2026.03.016_bib366","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa065044","article-title":"Sunitinib versus interferon alfa in metastatic renal-cell carcinoma","volume":"356","author":"Motzer","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib332","doi-asserted-by":"crossref","first-page":"17561","DOI":"10.1073\/pnas.1215397109","article-title":"Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy","volume":"109","author":"Huang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2026.03.016_bib367","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/nature21724","article-title":"Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming","volume":"544","author":"Tian","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.016_bib368","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1002\/hep.30889","article-title":"Dual Programmed Death Receptor-1 and Vascular Endothelial Growth Factor Receptor-2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma","volume":"71","author":"Shigeta","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.cell.2026.03.016_bib369","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1172\/JCI96582","article-title":"Increased vessel perfusion predicts the efficacy of immune checkpoint blockade","volume":"128","author":"Zheng","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cell.2026.03.016_bib370","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib371","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1056\/NEJMoa2035716","article-title":"Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma","volume":"384","author":"Motzer","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib46","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/s41568-024-00745-z","article-title":"Compressive stresses in cancer: characterization and implications for tumour progression and treatment","volume":"24","author":"Linke","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2026.03.016_bib372","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3516","article-title":"Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels","volume":"4","author":"Chauhan","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2026.03.016_bib296","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005583","article-title":"Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice","volume":"11","author":"Dong","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.cell.2026.03.016_bib352","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2024.08.1785","article-title":"1692P A phase Ib\/IIa trial to evaluate the safety and efficacy of PM8002\/ BNT327, a bispecific antibody targeting PD-L1 and VEGF-A, as a monotherapy in patients with advanced renal cell carcinoma","volume":"35","author":"Sheng","year":"2024","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.cell.2026.03.016_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaz0868","article-title":"Physical traits of cancer","volume":"370","author":"Nia","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.03.016_bib26","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.cell.2023.02.002","article-title":"Cancer neuroscience: State of the field, emerging directions","volume":"186","author":"Winkler","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.016_bib27","article-title":"A tumor metabolism-angiogenesis-immune axis governs immunotherapy responses","author":"Serganova","year":"2026","journal-title":"bioRxiv"},{"key":"10.1016\/j.cell.2026.03.016_bib28","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1016\/j.cell.2024.07.012","article-title":"A systems view of the vascular endothelium in health and disease","volume":"187","author":"Augustin","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.016_bib29","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.cell.2009.03.025","article-title":"The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis","volume":"137","author":"Benedito","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.016_bib30","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.cmet.2013.08.001","article-title":"Role of endothelial cell metabolism in vessel sprouting","volume":"18","author":"De Bock","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.cell.2026.03.016_bib31","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.cell.2009.01.020","article-title":"Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization","volume":"136","author":"Mazzone","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.016_bib32","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.cell.2013.06.037","article-title":"Role of PFKFB3-driven glycolysis in vessel sprouting","volume":"154","author":"De Bock","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.016_bib33","doi-asserted-by":"crossref","DOI":"10.1007\/s00281-024-01014-9","article-title":"Vascular galectins in tumor angiogenesis and cancer immunity","volume":"46","author":"Thijssen","year":"2024","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.cell.2026.03.016_bib34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10456-023-09876-7","article-title":"Pathological angiogenesis: mechanisms and therapeutic strategies","volume":"26","author":"Dudley","year":"2023","journal-title":"Angiogenesis"},{"key":"10.1016\/j.cell.2026.03.016_bib35","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ccr.2007.04.017","article-title":"Genes that distinguish physiological and pathological angiogenesis","volume":"11","author":"Seaman","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2026.03.016_bib36","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2424730122","article-title":"Embryonic reprogramming of the tumor vasculature reveals targets for cancer therapy","volume":"122","author":"Huijbers","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2026.03.016_bib37","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s43018-024-00780-7","article-title":"Milestones in tumor vascularization and its therapeutic targeting","volume":"5","author":"De Palma","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.cell.2026.03.016_bib38","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.omto.2021.07.001","article-title":"Long non-coding RNAs and circular RNAs in tumor angiogenesis: From mechanisms to clinical significance","volume":"22","author":"Liu","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.cell.2026.03.016_bib39","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1002\/jcb.26153","article-title":"LncRNA-MALAT1 Promotes Angiogenesis of Thyroid Cancer by Modulating Tumor-Associated Macrophage FGF2 Protein Secretion","volume":"118","author":"Huang","year":"2017","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.cell.2026.03.016_bib40","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.bjc.6604929","article-title":"Why are tumour blood vessels abnormal and why is it important to know?","volume":"100","author":"Nagy","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cell.2026.03.016_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/science.aal2379","article-title":"Organotypic vasculature: From descriptive heterogeneity to functional pathophysiology","volume":"357","author":"Augustin","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.03.016_bib42","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1158\/0008-5472.CAN-12-4521","article-title":"Coevolution of solid stress and interstitial fluid pressure in tumors during progression: implications for vascular collapse","volume":"73","author":"Stylianopoulos","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2026.03.016_bib43","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1158\/0008-5472.CAN-06-4102","article-title":"Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model","volume":"67","author":"Jain","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2026.03.016_bib44","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1126\/science.aaw7875","article-title":"Vascular regulation of antitumor immunity","volume":"365","author":"Munn","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.03.016_bib45","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1073\/pnas.1018154108","article-title":"Scaling rules for diffusive drug delivery in tumor and normal tissues","volume":"108","author":"Baish","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2026.03.016_bib47","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1038\/s41592-024-02564-4","article-title":"Probing the physical hallmarks of cancer","volume":"22","author":"Nia","year":"2025","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cell.2026.03.016_bib48","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41551-018-0334-7","article-title":"Solid stress in brain tumours causes neuronal loss and neurological dysfunction and can be reversed by lithium","volume":"3","author":"Seano","year":"2019","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.cell.2026.03.016_bib49","doi-asserted-by":"crossref","DOI":"10.1186\/s40164-025-00647-2","article-title":"Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer","volume":"14","author":"Zhang","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.cell.2026.03.016_bib50","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1172\/JCI74725","article-title":"Lysyl hydroxylase 2 induces a collagen cross-link switch in tumor stroma","volume":"125","author":"Chen","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cell.2026.03.016_bib51","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1038\/sj.onc.1204500","article-title":"Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells","volume":"20","author":"Shi","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.cell.2026.03.016_bib52","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","article-title":"Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1","volume":"16","author":"Forsythe","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cell.2026.03.016_bib53","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/s41577-025-01187-w","article-title":"Tumour-associated vasculature in T cell homing and immunity: opportunities for cancer therapy","volume":"25","author":"Lanitis","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cell.2026.03.016_bib54","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.ccell.2016.10.006","article-title":"Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy","volume":"30","author":"Cantelmo","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2026.03.016_bib55","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nature14362","article-title":"Fatty acid carbon is essential for dNTP synthesis in endothelial cells","volume":"520","author":"Schoors","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.016_bib56","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.celrep.2016.04.015","article-title":"Resistance to Antiangiogenic Therapies by Metabolic Symbiosis in Renal Cell Carcinoma PDX Models and Patients","volume":"15","author":"Jim\u00e9nez-Valerio","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.cell.2026.03.016_bib57","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.celrep.2016.04.028","article-title":"Targeting Metabolic Symbiosis to Overcome Resistance to Anti-angiogenic Therapy","volume":"15","author":"Pisarsky","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.cell.2026.03.016_bib58","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.celrep.2016.04.029","article-title":"Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling","volume":"15","author":"Allen","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.cell.2026.03.016_bib59","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41388-024-03228-5","article-title":"The influence of endothelial metabolic reprogramming on the tumor microenvironment","volume":"44","author":"Kane","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.cell.2026.03.016_bib61","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nm0603-685","article-title":"Molecular regulation of vessel maturation","volume":"9","author":"Jain","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib62","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/s41586-024-07283-6","article-title":"A brain-specific angiogenic mechanism enabled by tip cell specialization","volume":"628","author":"Schevenels","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.016_bib63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1535-7163.MCT-22-0243","article-title":"Targeting the DLL\/Notch Signaling Pathway in Cancer: Challenges and Advances in Clinical Development","volume":"22","author":"You","year":"2023","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.cell.2026.03.016_bib64","article-title":"Angiogenesis-on-a-chip coupled with single-cell RNA sequencing reveals spatially differential activations of autophagy along angiogenic sprouts","volume":"15","author":"Lee","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2026.03.016_bib65","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1042\/BST20253048","article-title":"Temporal dynamics of angiogenesis: the emerging role of mechanoregulated pathways","volume":"53","author":"Zarin-Bal","year":"2025","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.cell.2026.03.016_bib66","doi-asserted-by":"crossref","DOI":"10.1038\/s41540-024-00444-3","article-title":"YAP\/TAZ drives Notch and angiogenesis mechanoregulation in silico","volume":"10","author":"Passier","year":"2024","journal-title":"NPJ Syst. Biol. Appl."},{"key":"10.1016\/j.cell.2026.03.016_bib67","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1161\/ATVBAHA.123.320599","article-title":"Identification of New Markers of Angiogenic Sprouting Using Transcriptomics: New Role for RND3","volume":"44","author":"Abbey","year":"2024","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cell.2026.03.016_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.612774","article-title":"Different Forms of Tumor Vascularization and Their Clinical Implications Focusing on Vessel Co-option in Colorectal Cancer Liver Metastases","volume":"9","author":"Haas","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.cell.2026.03.016_bib69","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10456-014-9428-3","article-title":"Intussusceptive angiogenesis: expansion and remodeling of microvascular networks","volume":"17","author":"Mentzer","year":"2014","journal-title":"Angiogenesis"},{"key":"10.1016\/j.cell.2026.03.016_bib70","first-page":"81","article-title":"Microvascular density, vascular endothelial growth factor immunoreactivity in tumor cells, vessel diameter and intussusceptive microvascular growth in primary melanoma","volume":"14","author":"Ribatti","year":"2005","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.cell.2026.03.016_bib71","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10238-009-0076-7","article-title":"Intussusceptive microvascular growth in human glioma","volume":"10","author":"Nico","year":"2010","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib72","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1006\/mvre.1996.0025","article-title":"Intussusceptive microvascular growth in a human colon adenocarcinoma xenograft: a novel mechanism of tumor angiogenesis","volume":"51","author":"Patan","year":"1996","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.cell.2026.03.016_bib73","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.ajpath.2021.07.009","article-title":"Intussusceptive Angiogenesis in Human Metastatic Malignant Melanoma","volume":"191","author":"Pandita","year":"2021","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cell.2026.03.016_bib74","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2423700122","article-title":"Intussusceptive angiogenesis-on-a-chip: Evidence for transluminal vascular bridging by endothelial delamination","volume":"122","author":"Staples","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2026.03.016_bib75","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41571-019-0181-9","article-title":"Vessel co-option in cancer","volume":"16","author":"Kuczynski","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cell.2026.03.016_bib76","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrn2175","article-title":"Angiogenesis in brain tumours","volume":"8","author":"Jain","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.cell.2026.03.016_bib77","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10456-019-09691-z","article-title":"Vessel co-option in glioblastoma: emerging insights and opportunities","volume":"23","author":"Seano","year":"2020","journal-title":"Angiogenesis"},{"key":"10.1016\/j.cell.2026.03.016_bib78","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/nm.4197","article-title":"Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases","volume":"22","author":"Frentzas","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib79","doi-asserted-by":"crossref","first-page":"39795","DOI":"10.18632\/oncotarget.7794","article-title":"Angiogenesis in NSCLC: is vessel co-option the trunk that sustains the branches?","volume":"8","author":"Coelho","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cell.2026.03.016_bib80","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10456-019-09684-y","article-title":"Models and molecular mechanisms of blood vessel co-option by cancer cells","volume":"23","author":"Zhang","year":"2020","journal-title":"Angiogenesis"},{"key":"10.1016\/j.cell.2026.03.016_bib81","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.ccell.2018.03.020","article-title":"A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment","volume":"33","author":"Griveau","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2026.03.016_bib82","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0002-9440(10)64740-2","article-title":"Vasculogenic mimicry: how convincing, how novel, and how significant?","volume":"156","author":"McDonald","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cell.2026.03.016_bib83","doi-asserted-by":"crossref","first-page":"299","DOI":"10.20892\/j.issn.2095-3941.2018.0209","article-title":"Cancer stem-like cells directly participate in vasculogenic mimicry channels in triple-negative breast cancer","volume":"16","author":"Sun","year":"2019","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib84","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/neuonc\/not029","article-title":"CDH5 is specifically activated in glioblastoma stemlike cells and contributes to vasculogenic mimicry induced by hypoxia","volume":"15","author":"Mao","year":"2013","journal-title":"Neuro. Oncol"},{"key":"10.1016\/j.cell.2026.03.016_bib85","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0002-9440(10)65173-5","article-title":"Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry","volume":"155","author":"Maniotis","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cell.2026.03.016_bib86","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/bs.acr.2020.06.001","article-title":"Vascular mimicry: Triggers, molecular interactions and in vivo models","volume":"148","author":"Wechman","year":"2020","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.cell.2026.03.016_bib87","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/nm1448","article-title":"Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness","volume":"12","author":"Topczewska","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib88","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.canlet.2006.08.016","article-title":"Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related protein expression in melanoma","volume":"249","author":"Sun","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cell.2026.03.016_bib89","first-page":"3250","article-title":"Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck\/EphA2)","volume":"61","author":"Hess","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2026.03.016_bib90","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/nature09557","article-title":"Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells","volume":"468","author":"Ricci-Vitiani","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.016_bib91","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1073\/pnas.1016030108","article-title":"Transdifferentiation of glioblastoma cells into vascular endothelial cells","volume":"108","author":"Soda","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2026.03.016_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118013","article-title":"Current knowledge on the mechanisms underpinning vasculogenic mimicry in triple negative breast cancer and the emerging role of nitric oxide","volume":"186","author":"Alemu","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cell.2026.03.016_bib93","doi-asserted-by":"crossref","first-page":"7843","DOI":"10.1158\/0008-5472.CAN-06-1010","article-title":"Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor","volume":"66","author":"Bao","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2026.03.016_bib94","doi-asserted-by":"crossref","first-page":"30502","DOI":"10.18632\/oncotarget.8461","article-title":"Epithelial-to-endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumors","volume":"8","author":"Sun","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cell.2026.03.016_bib95","article-title":"ETV2 mediates endothelial transdifferentiation of glioblastoma","volume":"3","author":"Zhao","year":"2018","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cell.2026.03.016_bib96","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-023-10659-y","article-title":"Characteristics of vasculogenic mimicry and tumour to endothelial transdifferentiation in human glioblastoma: a systematic review","volume":"23","author":"Maddison","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cell.2026.03.016_bib97","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cell.2013.02.021","article-title":"Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth","volume":"153","author":"Cheng","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.016_bib98","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3892\/ol.2016.4733","article-title":"Endothelial progenitor cells promote tumor growth and progression by enhancing new vessel formation","volume":"12","author":"Zhao","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.cell.2026.03.016_bib99","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.it.2007.05.007","article-title":"The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis","volume":"28","author":"Petit","year":"2007","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cell.2026.03.016_bib100","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S1535-6108(03)00138-7","article-title":"Role of bone marrow-derived cells in tumor angiogenesis and treatment","volume":"3","author":"Jain","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2026.03.016_bib101","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1101\/gad.436307","article-title":"Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization","volume":"21","author":"Nolan","year":"2007","journal-title":"Genes Dev."},{"key":"10.1016\/j.cell.2026.03.016_bib102","doi-asserted-by":"crossref","first-page":"6620","DOI":"10.1073\/pnas.0710516105","article-title":"Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth","volume":"105","author":"Purhonen","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2026.03.016_bib103","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1158\/1078-0432.CCR-13-0462","article-title":"Cell trafficking of endothelial progenitor cells in tumor progression","volume":"19","author":"de la Puente","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cell.2026.03.016_bib104","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccr.2005.08.002","article-title":"Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors","volume":"8","author":"De Palma","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2026.03.016_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17111804","article-title":"Bone Marrow Myeloid-Lymphatic Progenitors Expand Tumor Lymphatic Vasculature Through Cell Fusion","volume":"17","author":"Athaiya","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cell.2026.03.016_bib106","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-07961-w","article-title":"Endovascular progenitors infiltrate melanomas and differentiate towards a variety of vascular beds promoting tumor metastasis","volume":"10","author":"Donovan","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2026.03.016_bib107","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12062399","article-title":"Vascular Progenitor Cells: From Cancer to Tissue Repair","volume":"12","author":"Barachini","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib108","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1242\/dev.003244","article-title":"Endothelial signalling by the Notch ligand Delta-like 4 restricts angiogenesis","volume":"134","author":"Leslie","year":"2007","journal-title":"Development"},{"key":"10.1016\/j.cell.2026.03.016_bib109","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1073\/pnas.0611206104","article-title":"Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting","volume":"104","author":"Lobov","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2026.03.016_bib110","doi-asserted-by":"crossref","DOI":"10.3390\/cells10030639","article-title":"Overview on the Different Patterns of Tumor Vascularization","volume":"10","author":"Ribatti","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.cell.2026.03.016_bib111","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/jcp-2024-209703","article-title":"Vascular mimicry and mosaic vessels in parathyroid tumours: a new diagnostic approach?","volume":"78","author":"Falleni","year":"2025","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.cell.2026.03.016_bib112","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1481726","article-title":"Vasculogenic mimicry in non-small cell lung cancer: a systematic review","volume":"15","author":"Shapkina","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cell.2026.03.016_bib113","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cell.2006.12.029","article-title":"FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis","volume":"128","author":"Paik","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.016_bib114","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature16498","article-title":"FOXO1 couples metabolic activity and growth state in the vascular endothelium","volume":"529","author":"Wilhelm","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.016_bib115","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41556-021-00637-6","article-title":"Control of endothelial quiescence by FOXO-regulated metabolites","volume":"23","author":"Andrade","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cell.2026.03.016_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109161","article-title":"FOXO1 stimulates tip cell-enriched gene expression in endothelial cells","volume":"27","author":"Miyamura","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.cell.2026.03.016_bib117","first-page":"2641","article-title":"Determinants of tumor blood flow: a review","volume":"48","author":"Jain","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2026.03.016_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119407","article-title":"Matrix stiffness regulates SMC functions via TGF-\u03b2 signaling pathway","volume":"221","author":"Tian","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.cell.2026.03.016_bib119","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.trecan.2025.06.005","article-title":"Pericyte phenotype switching in cancer","volume":"11","author":"He","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.cell.2026.03.016_bib120","doi-asserted-by":"crossref","DOI":"10.1172\/JCI179860","article-title":"Pericyte phenotype switching alleviates immunosuppression and sensitizes vascularized tumors to immunotherapy in preclinical models","volume":"134","author":"Li","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cell.2026.03.016_bib121","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nature06868","article-title":"Vascular normalization in Rgs5-deficient tumours promotes immune destruction","volume":"453","author":"Hamzah","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.016_bib122","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10456-007-9085-x","article-title":"RGS5 expression is a quantitative measure of pericyte coverage of blood vessels","volume":"11","author":"Mitchell","year":"2008","journal-title":"Angiogenesis"},{"key":"10.1016\/j.cell.2026.03.016_bib123","article-title":"TET2-mediated tumor cGAS triggers endothelial STING activation to regulate vasculature remodeling and anti-tumor immunity in liver cancer","volume":"15","author":"Lv","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2026.03.016_bib124","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.add1153","article-title":"STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy","volume":"8","author":"Wang-Bishop","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.cell.2026.03.016_bib125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2006.09.002","article-title":"Myeloid cell trafficking and tumor angiogenesis","volume":"250","author":"Schmid","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cell.2026.03.016_bib126","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1295257","article-title":"Tumor-associated macrophages: an effective player of the tumor microenvironment","volume":"14","author":"Basak","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cell.2026.03.016_bib127","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1158\/0008-5472.CAN-23-3987","article-title":"Cancer-Associated Fibroblasts Expressing Sulfatase 1 Facilitate VEGFA-Dependent Microenvironmental Remodeling to Support Colorectal Cancer","volume":"84","author":"Wang","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2026.03.016_bib128","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1582532","article-title":"Revisiting the role of cancer-associated fibroblasts in tumor microenvironment","volume":"16","author":"Lan","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cell.2026.03.016_bib129","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.trecan.2023.06.010","article-title":"Perivascular niches: critical hubs in cancer evolution","volume":"9","author":"Nowosad","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.cell.2026.03.016_bib135","doi-asserted-by":"crossref","DOI":"10.1038\/s41377-020-0295-y","article-title":"Spatial heterogeneity of oxygenation and haemodynamics in breast cancer resolved in vivo by conical multispectral optoacoustic mesoscopy","volume":"9","author":"Li","year":"2020","journal-title":"Light Sci. Appl."},{"key":"10.1016\/j.cell.2026.03.016_bib136","article-title":"Spatial transcriptomics reveals substantial heterogeneity in triple-negative breast cancer with potential clinical implications","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2026.03.016_bib137","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1158\/1078-0432.CCR-22-0486","article-title":"Multiphoton Phosphorescence Quenching Microscopy Reveals Kinetics of Tumor Oxygenation during Antiangiogenesis and Angiotensin Signaling Inhibition","volume":"28","author":"Martin","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cell.2026.03.016_bib130","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41568-024-00681-y","article-title":"Lymphatic vessels in the age of cancer immunotherapy","volume":"24","author":"Karakousi","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2026.03.016_bib131","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41586-019-1912-x","article-title":"VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours","volume":"577","author":"Song","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.016_bib132","article-title":"Lymphatic transport in anti-tumor immunity and metastasis","volume":"222","author":"Sun","year":"2025","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib133","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1182\/blood-2006-05-021758","article-title":"VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites","volume":"109","author":"Hirakawa","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cell.2026.03.016_bib134","article-title":"Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets","volume":"9","author":"Hu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cell.2026.03.016_bib138","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41586-024-07698-1","article-title":"Tumour vasculature at single-cell resolution","volume":"632","author":"Pan","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.016_bib139","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.cell.2020.01.015","article-title":"Single-Cell Transcriptome Atlas of Murine Endothelial Cells","volume":"180","author":"Kalucka","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.016_bib140","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/cvr\/cvac018","article-title":"Deciphering endothelial heterogeneity in health and disease at single-cell resolution: progress and perspectives","volume":"119","author":"Becker","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cell.2026.03.016_bib141","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/ncb2103","article-title":"Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting","volume":"12","author":"Jakobsson","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cell.2026.03.016_bib142","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006569","article-title":"VEGF and Notch in tip and stalk cell selection","volume":"3","author":"Blanco","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib143","first-page":"466","article-title":"Dll4\/Notch1 signaling from tip\/stalk endothelial cell specification to stroma-dependent lung tumor inhibition: a flavor of Dll4\/Notch1 pleiotropy in tumor cell biology","volume":"2","author":"Brizzi","year":"2013","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.cell.2026.03.016_bib144","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10456-021-09797-3","article-title":"Endothelial cell plasticity at the single-cell level","volume":"24","author":"Pasut","year":"2021","journal-title":"Angiogenesis"},{"key":"10.1016\/j.cell.2026.03.016_bib145","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00441-023-03741-1","article-title":"The role of PLVAP in endothelial cells","volume":"392","author":"Denzer","year":"2023","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.cell.2026.03.016_bib146","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2024.1351753","article-title":"Endothelial cells signaling and patterning under hypoxia: a mechanistic integrative computational model including the Notch-Dll4 pathway","volume":"15","author":"Oliveira","year":"2024","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cell.2026.03.016_bib147","doi-asserted-by":"crossref","DOI":"10.1172\/JCI169314","article-title":"Immune checkpoint blockade induces distinct alterations in the microenvironments of primary and metastatic brain tumors","volume":"133","author":"Sun","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cell.2026.03.016_bib148","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1158\/2767-9764.CRC-24-0201","article-title":"Spatial Multiomics Reveals Intratumoral Immune Heterogeneity with Distinct Cytokine Networks in Lung Cancer Brain Metastases","volume":"4","author":"Christensson","year":"2024","journal-title":"Cancer Res Commun."},{"key":"10.1016\/j.cell.2026.03.016_bib149","article-title":"Cancer-Associated Fibroblasts Arising from Endothelial-to-Mesenchymal Transition: Induction Factors, Functional Roles, and Transcriptomic Evidence","volume":"14","author":"Han","year":"2025","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.cell.2026.03.016_bib150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.736670","article-title":"High Endothelial Venules: A Vascular Perspective on Tertiary Lymphoid Structures in Cancer","volume":"12","author":"Vella","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cell.2026.03.016_bib151","article-title":"Single-cell and spatial transcriptomics implicate a prognostic function of tertiary lymphoid structures in gastric cancer","volume":"16","author":"Wang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2026.03.016_bib152","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1158\/0008-5472.CAN-11-0431","article-title":"Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer","volume":"71","author":"Martinet","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2026.03.016_bib153","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2007.15.0284","article-title":"Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures","volume":"26","author":"Dieu-Nosjean","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cell.2026.03.016_bib154","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.016_bib155","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.016_bib156","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","article-title":"B cells are associated with survival and immunotherapy response in sarcoma","volume":"577","author":"Petitprez","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.016_bib157","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-022-05680-3","article-title":"Single-cell spatial immune landscapes of primary and metastatic brain tumours","volume":"614","author":"Karimi","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.016_bib158","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1515","article-title":"Single-cell and spatial transcriptomics reveal POSTN+ cancer-associated fibroblasts correlated with immune suppression and tumour progression in non-small cell lung cancer","volume":"13","author":"Chen","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib159","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41586-025-08927-x","article-title":"Spatial mapping of transcriptomic plasticity in metastatic pancreatic cancer","volume":"642","author":"Pei","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.016_bib160","doi-asserted-by":"crossref","first-page":"7232","DOI":"10.1016\/j.cell.2024.09.024","article-title":"Disruption of cellular plasticity by repeat RNAs in human pancreatic cancer","volume":"187","author":"You","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.016_bib166","article-title":"The spatial transcriptomic landscape of non-small cell lung cancer brain metastasis","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2026.03.016_bib167","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-48700-8","article-title":"Single-cell and spatial transcriptomics analysis of non-small cell lung cancer","volume":"15","author":"De Zuani","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2026.03.016_bib161","article-title":"Spatially resolved atlas of breast cancer uncovers intercellular machinery of venular niche governing lymphocyte extravasation","volume":"16","author":"Wang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2026.03.016_bib162","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-26271-2","article-title":"Spatial deconvolution of HER2-positive breast cancer delineates tumor-associated cell type interactions","volume":"12","author":"Andersson","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2026.03.016_bib163","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","article-title":"A single-cell and spatially resolved atlas of human breast cancers","volume":"53","author":"Wu","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cell.2026.03.016_bib169","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1038\/s41588-024-01914-4","article-title":"Spatial transcriptomic analysis of primary and metastatic pancreatic cancers highlights tumor microenvironmental heterogeneity","volume":"56","author":"Khaliq","year":"2024","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cell.2026.03.016_bib164","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.cell.2024.03.029","article-title":"Integrative spatial analysis reveals a multi-layered organization of glioblastoma","volume":"187","author":"Greenwald","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.016_bib165","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-36707-6","article-title":"Spatial transcriptomics reveals niche-specific enrichment and vulnerabilities of radial glial stem-like cells in malignant gliomas","volume":"14","author":"Ren","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2026.03.016_bib168","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-025-02287-w","article-title":"Single-cell and spatial transcriptomic analyses revealing tumor microenvironment remodeling after neoadjuvant chemoimmunotherapy in non-small cell lung cancer","volume":"24","author":"Cui","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cell.2026.03.016_bib170","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1158\/0008-5472.CAN-11-2464","article-title":"Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusion","volume":"72","author":"Sorensen","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2026.03.016_bib171","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.612271","article-title":"Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins","volume":"12","author":"Liot","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cell.2026.03.016_bib172","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14246167","article-title":"Renal Carcinoma and Angiogenesis: Therapeutic Target and Biomarkers of Response in Current Therapies","volume":"14","author":"Guillaume","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cell.2026.03.016_bib173","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ccr.2009.01.027","article-title":"Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis","volume":"15","author":"P\u00e0ez-Ribes","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2026.03.016_bib174","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s11481-014-9531-7","article-title":"Vascular endothelial growth factor signaling in hypoxia and inflammation","volume":"9","author":"Ramakrishnan","year":"2014","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.cell.2026.03.016_bib175","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.canlet.2020.05.012","article-title":"Hypoxia-induced epithelial to mesenchymal transition in cancer","volume":"487","author":"Hapke","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cell.2026.03.016_bib176","doi-asserted-by":"crossref","first-page":"8065","DOI":"10.1158\/0008-5472.CAN-06-1392","article-title":"Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications","volume":"66","author":"Hoshida","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2026.03.016_bib177","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/nm.2545","article-title":"The lymphatic vasculature in disease","volume":"17","author":"Alitalo","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib178","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1172\/JCI73316","article-title":"Emerging roles of lymphatic endothelium in regulating adaptive immunity","volume":"124","author":"Card","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cell.2026.03.016_bib179","doi-asserted-by":"crossref","first-page":"14325","DOI":"10.1073\/pnas.1518808112","article-title":"Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients","volume":"112","author":"Tolaney","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2026.03.016_bib180","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1073\/pnas.1424024112","article-title":"Improved tumor vascularization after anti-VEGF therapy with carboplatin and nab-paclitaxel associates with survival in lung cancer","volume":"112","author":"Heist","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2026.03.016_bib181","doi-asserted-by":"crossref","first-page":"19059","DOI":"10.1073\/pnas.1318022110","article-title":"Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation","volume":"110","author":"Batchelor","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2026.03.016_bib182","doi-asserted-by":"crossref","first-page":"18632","DOI":"10.1073\/pnas.1318415110","article-title":"Combining two strategies to improve perfusion and drug delivery in solid tumors","volume":"110","author":"Stylianopoulos","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2026.03.016_bib183","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41571-019-0308-z","article-title":"Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges","volume":"17","author":"Martin","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cell.2026.03.016_bib185","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.ajpath.2024.08.017","article-title":"Discovery and Mechanistic Insights into Vascular Permeability Factor\/Vascular Endothelial Growth Factor through the Work of Harold F. Dvorak and Ann M. Dvorak","volume":"195","author":"Galli","year":"2025","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cell.2026.03.016_bib186","doi-asserted-by":"crossref","DOI":"10.1172\/JCI161366","article-title":"Endothelial VEGFR2-PLC\u03b3 signaling regulates vascular permeability and antitumor immunity through eNOS\/Src","volume":"133","author":"Sj\u00f6berg","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cell.2026.03.016_bib187","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/joim.12019","article-title":"VEGFA and tumour angiogenesis","volume":"273","author":"Claesson-Welsh","year":"2013","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib188","article-title":"Identification of kinases activated by multiple pro-angiogenic growth factors","volume":"13","author":"Gruver","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cell.2026.03.016_bib189","doi-asserted-by":"crossref","first-page":"9349","DOI":"10.1073\/pnas.95.16.9349","article-title":"Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice","volume":"95","author":"Hiratsuka","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2026.03.016_bib190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006525","article-title":"VEGFR1 activity modulates myeloid cell infiltration in growing lung metastases but is not required for spontaneous metastasis formation","volume":"4","author":"Dawson","year":"2009","journal-title":"PLOS One"},{"key":"10.1016\/j.cell.2026.03.016_bib191","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nature04186","article-title":"VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche","volume":"438","author":"Kaplan","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.016_bib192","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1535-6108(02)00153-8","article-title":"MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis","volume":"2","author":"Hiratsuka","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2026.03.016_bib193","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/nature07424","article-title":"A role for VEGF as a negative regulator of pericyte function and vessel maturation","volume":"456","author":"Greenberg","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.016_bib194","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1158\/1078-0432.CCR-11-0659","article-title":"Beyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesis","volume":"17","author":"Lieu","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cell.2026.03.016_bib195","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag0945","article-title":"Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2","volume":"10","author":"Incio","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib196","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1172\/JCI200318549","article-title":"Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors","volume":"112","author":"Abramsson","year":"2003","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cell.2026.03.016_bib197","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.devcel.2011.07.001","article-title":"Pericytes: developmental, physiological, and pathological perspectives, problems, and promises","volume":"21","author":"Armulik","year":"2011","journal-title":"Dev. Cell"},{"key":"10.1016\/j.cell.2026.03.016_bib198","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0008-6363(00)00281-9","article-title":"Molecular mechanisms of blood vessel growth","volume":"49","author":"Conway","year":"2001","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cell.2026.03.016_bib199","doi-asserted-by":"crossref","DOI":"10.1038\/s41421-017-0002-1","article-title":"Dual roles of endothelial FGF-2-FGFR1-PDGF-BB and perivascular FGF-2-FGFR2-PDGFR\u03b2 signaling pathways in tumor vascular remodeling","volume":"4","author":"Hosaka","year":"2018","journal-title":"Cell Discov."},{"key":"10.1016\/j.cell.2026.03.016_bib200","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1172\/JCI200320087","article-title":"What brings pericytes to tumor vessels?","volume":"112","author":"Jain","year":"2003","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cell.2026.03.016_bib201","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114491","article-title":"New insights about the PDGF\/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies","volume":"161","author":"Pandey","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cell.2026.03.016_bib202","doi-asserted-by":"crossref","first-page":"10090","DOI":"10.1158\/0008-5472.CAN-10-0489","article-title":"HGF\/c-Met acts as an alternative angiogenic pathway in sunitinib-resistant tumors","volume":"70","author":"Shojaei","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2026.03.016_bib203","doi-asserted-by":"crossref","first-page":"38205","DOI":"10.1074\/jbc.M203781200","article-title":"Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells","volume":"277","author":"Fukuda","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cell.2026.03.016_bib204","first-page":"3915","article-title":"Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2","volume":"59","author":"Feldser","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2026.03.016_bib205","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0092-8674(00)81813-9","article-title":"Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis","volume":"87","author":"Suri","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.016_bib206","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0092-8674(00)81812-7","article-title":"Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning","volume":"87","author":"Davis","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.016_bib207","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/376070a0","article-title":"Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation","volume":"376","author":"Sato","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.016_bib208","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1126\/science.284.5422.1994","article-title":"Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF","volume":"284","author":"Holash","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.03.016_bib209","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.277.5322.55","article-title":"Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis","volume":"277","author":"Maisonpierre","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.03.016_bib210","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.ccell.2016.10.018","article-title":"Normalization of Tumor Vessels by Tie2 Activation and Ang2 Inhibition Enhances Drug Delivery and Produces a Favorable Tumor Microenvironment","volume":"30","author":"Park","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2026.03.016_bib211","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nrd.2016.278","article-title":"Therapeutic targeting of the angiopoietin-TIE pathway","volume":"16","author":"Saharinen","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cell.2026.03.016_bib212","article-title":"Notch signaling pathway in cancer: from mechanistic insights to targeted therapies","volume":"9","author":"Shi","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cell.2026.03.016_bib213","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2021.101626","article-title":"Progress in understanding of the stalk and tip cells formation involvement in angiogenesis mechanisms","volume":"73","author":"Zeng","year":"2021","journal-title":"Tissue Cell"},{"key":"10.1016\/j.cell.2026.03.016_bib214","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201745054","article-title":"EphrinB2\/EphB4 signaling regulates non-sprouting angiogenesis by VEGF","volume":"19","author":"Groppa","year":"2018","journal-title":"EMBO Rep."},{"key":"10.1016\/j.cell.2026.03.016_bib215","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/archotol.134.9.985","article-title":"The significance of EphB4 and EphrinB2 expression and survival in head and neck squamous cell carcinoma","volume":"134","author":"Yavrouian","year":"2008","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.cell.2026.03.016_bib216","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1007\/s00018-014-1633-0","article-title":"Eph- and ephrin-dependent mechanisms in tumor and stem cell dynamics","volume":"71","author":"Gucciardo","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cell.2026.03.016_bib217","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-31124-7","article-title":"EphB4 and ephrinB2 act in opposition in the head and neck tumor microenvironment","volume":"13","author":"Bhatia","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2026.03.016_bib218","doi-asserted-by":"crossref","first-page":"444","DOI":"10.18632\/oncotarget.28605","article-title":"Improved efficacy of pembrolizumab combined with soluble EphB4-albumin in HPV-negative EphrinB2 positive head neck squamous cell carcinoma","volume":"15","author":"Jackovich","year":"2024","journal-title":"Oncotarget"},{"key":"10.1016\/j.cell.2026.03.016_bib219","doi-asserted-by":"crossref","first-page":"7063","DOI":"10.1038\/s41388-020-01473-y","article-title":"Ephrin-B2-EphB4 communication mediates tumor-endothelial cell interactions during hematogenous spread to spinal bone in a melanoma metastasis model","volume":"39","author":"Broggini","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.cell.2026.03.016_bib220","article-title":"Hypoxia-driven angiogenesis and metabolic reprogramming in vascular tumors","volume":"13","author":"Liu","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.cell.2026.03.016_bib221","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing","volume":"292","author":"Ivan","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.03.016_bib222","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/584758","article-title":"Hypoxia Inducible Factor Pathway and Physiological Adaptation: A Cell Survival Pathway?","volume":"2015","author":"Kumar","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.cell.2026.03.016_bib223","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1158\/0008-5472.CAN-24-2324","article-title":"HIF1\u03b1 Counteracts TGF\u03b21-Driven TSP1 Expression in Endothelial Cells to Stimulate Angiogenesis in the Hypoxic Tumor Microenvironment","volume":"85","author":"Luo","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2026.03.016_bib224","article-title":"NF-\u03baB in biology and targeted therapy: new insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cell.2026.03.016_bib225","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41423-025-01310-w","article-title":"NF-\u03baB in inflammation and cancer","volume":"22","author":"Mao","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.cell.2026.03.016_bib226","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1093\/nar\/gki836","article-title":"NF-kappaB controls the global pro-inflammatory response in endothelial cells: evidence for the regulation of a pro-atherogenic program","volume":"33","author":"Kempe","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cell.2026.03.016_bib227","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1084\/jem.20111343","article-title":"VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd","volume":"209","author":"Sun","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib228","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-025-00779-x","article-title":"Decoding tumor angiogenesis: pathways, mechanisms, and future directions in anti-cancer strategies","volume":"13","author":"Liu","year":"2025","journal-title":"Biomark. Res."},{"key":"10.1016\/j.cell.2026.03.016_bib229","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7150\/ijbs.66839","article-title":"Validation of ESM1 Related to Ovarian Cancer and the Biological Function and Prognostic Significance","volume":"19","author":"Li","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cell.2026.03.016_bib230","article-title":"Regulation of cancer cell metabolism: oncogenic MYC in the driver's seat","volume":"5","author":"Dong","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cell.2026.03.016_bib231","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.devcel.2019.07.022","article-title":"A Yap-Myc-Sox2-p53 Regulatory Network Dictates Metabolic Homeostasis and Differentiation in Kras-Driven Pancreatic Ductal Adenocarcinomas","volume":"51","author":"Murakami","year":"2019","journal-title":"Dev. Cell"},{"key":"10.1016\/j.cell.2026.03.016_bib232","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.semcancer.2018.01.004","article-title":"FoxO transcription factors in cancer metabolism","volume":"50","author":"Yadav","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.cell.2026.03.016_bib233","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s42255-022-00584-y","article-title":"A YAP\/TAZ-TEAD signalling module links endothelial nutrient acquisition to angiogenic growth","volume":"4","author":"Ong","year":"2022","journal-title":"Nat. Metab."},{"key":"10.1016\/j.cell.2026.03.016_bib234","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17183037","article-title":"Therapeutic Use of Integrin Signaling in Melanoma Cells: Physical Link with the Extracellular Matrix (ECM)","volume":"17","author":"Adamiak-Nikolouzou","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cell.2026.03.016_bib235","article-title":"Targeting integrin pathways: mechanisms and advances in therapy","volume":"8","author":"Pang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cell.2026.03.016_bib236","doi-asserted-by":"crossref","DOI":"10.3390\/cells13161336","article-title":"The Proangiogenic Effects of Melanoma-Derived Ectosomes Are Mediated by \u03b1v\u03b25 Integrin Rather than \u03b1v\u03b23 Integrin","volume":"13","author":"Surman","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.cell.2026.03.016_bib237","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1073\/pnas.1613855114","article-title":"Matrix stiffening promotes a tumor vasculature phenotype","volume":"114","author":"Bordeleau","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2026.03.016_bib238","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0102-27","article-title":"Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins","volume":"8","author":"Reynolds","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib239","doi-asserted-by":"crossref","DOI":"10.1186\/1479-5876-5-61","article-title":"A function blocking anti-mouse integrin alpha5beta1 antibody inhibits angiogenesis and impedes tumor growth in vivo","volume":"5","author":"Bhaskar","year":"2007","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib240","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.896099","article-title":"Insights Into the Role of Matrix Metalloproteinases in Cancer and its Various Therapeutic Aspects: A Review","volume":"9","author":"Mustafa","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.cell.2026.03.016_bib241","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01370","article-title":"Role of Matrix Metalloproteinases in Angiogenesis and Cancer","volume":"9","author":"Quintero-Fabi\u00e1n","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cell.2026.03.016_bib242","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/35036374","article-title":"Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis","volume":"2","author":"Bergers","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cell.2026.03.016_bib243","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-3-642-72149-6_8","article-title":"Endogenous angiogenesis inhibitors: angiostatin, endostatin, and other proteolytic fragments","volume":"20","author":"Cao","year":"1998","journal-title":"Prog. Mol. Subcell. Biol."},{"key":"10.1016\/j.cell.2026.03.016_bib244","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1101\/gad.14.2.163","article-title":"Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis","volume":"14","author":"Yu","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.cell.2026.03.016_bib245","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-025-00757-3","article-title":"Extracellular matrix: unlocking new avenues in cancer treatment","volume":"13","author":"Lee","year":"2025","journal-title":"Biomark. Res."},{"key":"10.1016\/j.cell.2026.03.016_bib246","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2025.164262","article-title":"Remodeling extracellular matrix to reverse apoptosis resistance by switchable bioadhesion nanoparticle with single-dose administration","volume":"516","author":"Ouyang","year":"2025","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.cell.2026.03.016_bib252","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaj1784","article-title":"The matricellular protein TSP1 promotes human and mouse endothelial cell senescence through CD47 and Nox1","volume":"10","author":"Meijles","year":"2017","journal-title":"Sci. Signal."},{"key":"10.1016\/j.cell.2026.03.016_bib262","doi-asserted-by":"crossref","first-page":"15404","DOI":"10.1074\/jbc.M701638200","article-title":"Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptake","volume":"282","author":"Isenberg","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cell.2026.03.016_bib254","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.bbagen.2015.09.007","article-title":"Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications","volume":"1850","author":"Walia","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cell.2026.03.016_bib255","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/08916930903510963","article-title":"Interferon-alpha as angiogenesis inhibitor: learning from tumor models","volume":"43","author":"Indraccolo","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.cell.2026.03.016_bib256","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/jnci\/95.6.437","article-title":"Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis","volume":"95","author":"von Marschall","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.cell.2026.03.016_bib257","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0002-9440(10)65007-9","article-title":"Inhibition of angiogenesis and vascular tumor growth by interferon-producing cells: A gene therapy approach","volume":"156","author":"Albini","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cell.2026.03.016_bib263","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.intimp.2005.08.010","article-title":"Modulation of IFN-gamma production by TNF-alpha in macrophages from the tumor environment: significance as an angiogenic switch","volume":"6","author":"Lee","year":"2006","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cell.2026.03.016_bib264","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.4049\/jimmunol.1103817","article-title":"Stabilization of HIF-2\u03b1 induces sVEGFR-1 production from tumor-associated macrophages and decreases tumor growth in a murine melanoma model","volume":"189","author":"Roda","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.cell.2026.03.016_bib265","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.4049\/jimmunol.1100841","article-title":"Hypoxia-inducible factor-2\u03b1 regulates GM-CSF-derived soluble vascular endothelial growth factor receptor 1 production from macrophages and inhibits tumor growth and angiogenesis","volume":"187","author":"Roda","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.cell.2026.03.016_bib266","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217308","article-title":"Role of semaphorins, neuropilins and plexins in cancer progression","volume":"606","author":"Fern\u00e1ndez-Nogueira","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cell.2026.03.016_bib267","article-title":"Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells","volume":"15","author":"Barnkob","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2026.03.016_bib268","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009372","article-title":"Leucine-rich \u03b1-2 glycoprotein 1 (LRG1) during inflammatory complications after allogeneic stem cell transplantation and CAR-T cell therapy","volume":"13","author":"Mertlitz","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.cell.2026.03.016_bib269","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah4807","article-title":"A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent","volume":"10","author":"Gioelli","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib253","article-title":"Active peptides of TSP-1 inhibit retinal angiogenesis through the CD36 pathway in a rat model of choroidal neovascularization","volume":"20","author":"Li","year":"2025","journal-title":"PLOS One"},{"key":"10.1016\/j.cell.2026.03.016_bib247","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nature05571","article-title":"Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis","volume":"445","author":"Hellstr\u00f6m","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.016_bib248","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1158\/0008-5472.CAN-19-0749","article-title":"Role of Apelin in Glioblastoma Vascularization and Invasion after Anti-VEGF Therapy: What Is the Impact on the Immune System?","volume":"79","author":"Amoozgar","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2026.03.016_bib249","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bjc.6602832","article-title":"Adrenomedullin and tumour angiogenesis","volume":"94","author":"Nikitenko","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cell.2026.03.016_bib250","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jhep.2023.10.006","article-title":"Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma","volume":"80","author":"Zhang","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cell.2026.03.016_bib258","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1182\/blood.V87.9.3877.bloodjournal8793877","article-title":"Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10","volume":"87","author":"Sgadari","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.cell.2026.03.016_bib259","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1126\/science.285.5425.245","article-title":"Pigment epithelium-derived factor: a potent inhibitor of angiogenesis","volume":"285","author":"Dawson","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.03.016_bib260","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1126\/science.1065298","article-title":"Tumstatin, an endothelial cell-specific inhibitor of protein synthesis","volume":"295","author":"Maeshima","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.03.016_bib261","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbamcr.2010.01.003","article-title":"The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity","volume":"1803","author":"Brew","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cell.2026.03.016_bib270","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1454456","article-title":"Pathogenic role of PFKFB3 in endothelial inflammatory diseases","volume":"11","author":"Zhou","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.cell.2026.03.016_bib271","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01750","article-title":"How Endothelial Cells Adapt Their Metabolism to Form Vessels in Tumors","volume":"8","author":"Zecchin","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cell.2026.03.016_bib272","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev-physiol-020518-114731","article-title":"Metabolic Pathways Fueling the Endothelial Cell Drive","volume":"81","author":"Li","year":"2019","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.cell.2026.03.016_bib273","article-title":"Targeting the SphK1\/S1P\/PFKFB3 axis suppresses hepatocellular carcinoma progression by disrupting glycolytic energy supply that drives tumor angiogenesis","volume":"22","author":"Liu","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib274","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cmet.2019.08.011","article-title":"Hallmarks of Endothelial Cell Metabolism in Health and Disease","volume":"30","author":"Li","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.cell.2026.03.016_bib275","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/joim.12016","article-title":"Endothelial cell metabolism and tumour angiogenesis: glucose and glutamine as essential fuels and lactate as the driving force","volume":"273","author":"Polet","year":"2013","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib276","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-26259-y","article-title":"Hexokinase 2-driven glycolysis in pericytes activates their contractility leading to tumor blood vessel abnormalities","volume":"12","author":"Meng","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2026.03.016_bib277","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.00077","article-title":"Metabolic Coordination of Pericyte Phenotypes: Therapeutic Implications","volume":"8","author":"Nwadozi","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.cell.2026.03.016_bib278","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021109890","article-title":"Endothelium-derived lactate is required for pericyte function and blood-brain barrier maintenance","volume":"41","author":"Lee","year":"2022","journal-title":"EMBO J."},{"key":"10.1016\/j.cell.2026.03.016_bib373","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2015.14","article-title":"Compensatory angiogenesis and tumor refractoriness","volume":"4","author":"Gacche","year":"2015","journal-title":"Oncogenesis"},{"key":"10.1016\/j.cell.2026.03.016_bib374","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1096\/fj.03-0271fje","article-title":"Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms","volume":"18","author":"Erber","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.cell.2026.03.016_bib375","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1323350","article-title":"Vascular co-option in resistance to anti-angiogenic therapy","volume":"13","author":"Ribatti","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cell.2026.03.016_bib376","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nrc2442","article-title":"Modes of resistance to anti-angiogenic therapy","volume":"8","author":"Bergers","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2026.03.016_bib377","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1158\/1078-0432.CCR-12-2535","article-title":"Predictive impact of circulating vascular endothelial growth factor in four phase III trials evaluating bevacizumab","volume":"19","author":"Hegde","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cell.2026.03.016_bib378","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1158\/1078-0432.CCR-12-3635","article-title":"Identification and analysis of in vivo VEGF downstream markers link VEGF pathway activity with efficacy of anti-VEGF therapies","volume":"19","author":"Brauer","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cell.2026.03.016_bib379","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrclinonc.2009.63","article-title":"Biomarkers of response and resistance to antiangiogenic therapy","volume":"6","author":"Jain","year":"2009","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cell.2026.03.016_bib279","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-023-06119-x","article-title":"Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications","volume":"14","author":"Fang","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cell.2026.03.016_bib280","first-page":"1111","article-title":"Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: the role of angiogenic factors","volume":"56","author":"Griffioen","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2026.03.016_bib281","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1002\/eji.200324270","article-title":"Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis","volume":"33","author":"Rodig","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cell.2026.03.016_bib282","doi-asserted-by":"crossref","first-page":"10770","DOI":"10.1158\/0008-5472.CAN-06-1609","article-title":"Epigenetic regulation of tumor endothelial cell anergy: silencing of intercellular adhesion molecule-1 by histone modifications","volume":"66","author":"Hellebrekers","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2026.03.016_bib283","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nm.3541","article-title":"Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors","volume":"20","author":"Motz","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib284","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189155","article-title":"Targeting endothelial cell anergy to improve CAR T cell therapy for solid tumors","volume":"1879","author":"Wachholz","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.cell.2026.03.016_bib285","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.semcancer.2018.06.002","article-title":"The reciprocal function and regulation of tumor vessels and immune cells offers new therapeutic opportunities in cancer","volume":"52","author":"Missiaen","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.cell.2026.03.016_bib286","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1152\/physrev.00046.2024","article-title":"Angiocrine and pericrine signaling: how endothelial cells and pericytes drive cancer progression and therapy resistance","volume":"106","author":"Jordan","year":"2026","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cell.2026.03.016_bib287","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.20021897","article-title":"An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4","volume":"197","author":"Lasagni","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib288","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1158\/1078-0432.CCR-19-1868","article-title":"Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade","volume":"26","author":"House","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cell.2026.03.016_bib289","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.00747","article-title":"Endothelial-to-Mesenchymal Transition in Cancer","volume":"8","author":"Clere","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.cell.2026.03.016_bib290","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ccell.2022.01.002","article-title":"Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy","volume":"40","author":"Asrir","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2026.03.016_bib291","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.ccell.2022.11.002","article-title":"Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop","volume":"40","author":"Hua","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2026.03.016_bib292","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aak9679","article-title":"Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation","volume":"9","author":"Allen","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib293","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1158\/0008-5472.CAN-22-2838","article-title":"Angiopoietin-2-Dependent Spatial Vascular Destabilization Promotes T-cell Exclusion and Limits Immunotherapy in Melanoma","volume":"83","author":"Park","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2026.03.016_bib294","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cmet.2023.01.010","article-title":"PHGDH-mediated endothelial metabolism drives glioblastoma resistance to chimeric antigen receptor T cell immunotherapy","volume":"35","author":"Zhang","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.cell.2026.03.016_bib295","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.coi.2015.01.011","article-title":"Targeting the tumor vasculature to enhance T cell activity","volume":"33","author":"Lanitis","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cell.2026.03.016_bib297","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/868475","article-title":"Combined effects of pericytes in the tumor microenvironment","volume":"2015","author":"Ribeiro","year":"2015","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.cell.2026.03.016_bib298","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.trsl.2014.01.011","article-title":"Pericyte-endothelial crosstalk: implications and opportunities for advanced cellular therapies","volume":"163","author":"Geevarghese","year":"2014","journal-title":"Transl. Res."},{"key":"10.1016\/j.cell.2026.03.016_bib299","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/s44318-024-00078-5","article-title":"Pericyte signaling via soluble guanylate cyclase shapes the vascular niche and microenvironment of tumors","volume":"43","author":"Zhu","year":"2024","journal-title":"EMBO J."},{"key":"10.1016\/j.cell.2026.03.016_bib300","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2026.03.016_bib301","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41568-025-00798-8","article-title":"The fibroinflammatory response in cancer","volume":"25","author":"Xiao","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2026.03.016_bib302","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1387198","article-title":"Signaling crosstalk between tumor endothelial cells and immune cells in the microenvironment of solid tumors","volume":"12","author":"Xu","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.cell.2026.03.016_bib303","article-title":"Role of the Extracellular Matrix in Cancer: Insights into Tumor Progression and Therapy","volume":"8","author":"Desai","year":"2025","journal-title":"Adv. Ther."},{"key":"10.1016\/j.cell.2026.03.016_bib304","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14041049","article-title":"Matrix Stiffness Contributes to Cancer Progression by Regulating Transcription Factors","volume":"14","author":"Ishihara","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cell.2026.03.016_bib305","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1016\/j.febslet.2014.04.012","article-title":"YAP\/TAZ as mechanosensors and mechanotransducers in regulating organ size and tumor growth","volume":"588","author":"Low","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cell.2026.03.016_bib306","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113213","article-title":"Mechanotransduction in response to ECM stiffening impairs cGAS immune signaling in tumor cells","volume":"42","author":"Liu","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.cell.2026.03.016_bib307","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-023-04810-3","article-title":"Matrix stiffness affects tumor-associated macrophage functional polarization and its potential in tumor therapy","volume":"22","author":"Xiong","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib308","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.784","article-title":"Neuroscience in peripheral cancers: tumors hijacking nerves and neuroimmune crosstalk","volume":"5","author":"Fan","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.cell.2026.03.016_bib309","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1530\/ERC-14-0236","article-title":"Adrenergic signaling promotes angiogenesis through endothelial cell-tumor cell crosstalk","volume":"21","author":"Chen","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.cell.2026.03.016_bib310","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.semcancer.2013.08.009","article-title":"\u03b2-Adrenergic system, a backstage manipulator regulating tumour progression and drug target in cancer therapy","volume":"23","author":"Tang","year":"2013","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.cell.2026.03.016_bib311","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1126\/science.aah5072","article-title":"Adrenergic nerves activate an angio-metabolic switch in prostate cancer","volume":"358","author":"Zahalka","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.03.016_bib312","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nature03875","article-title":"Common mechanisms of nerve and blood vessel wiring","volume":"436","author":"Carmeliet","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.016_bib313","article-title":"Neuro-immune crosstalk in cancer: mechanisms and therapeutic implications","volume":"10","author":"Pu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cell.2026.03.016_bib314","article-title":"Nervous system-gut microbiota-immune system axis: future directions for preventing tumor","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cell.2026.03.016_bib315","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105648","article-title":"Microbial-derived metabolites induce actin cytoskeletal rearrangement and protect blood-brain barrier function","volume":"25","author":"Knox","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.cell.2026.03.016_bib316","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.semcancer.2025.10.007","article-title":"From the gut to disease: Microbiota-derived short chain fatty acids and their precursors lactate and succinate in atherosclerosis and cancer","volume":"117","author":"Ced\u00f3","year":"2025","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.cell.2026.03.016_bib317","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.03.016_bib318","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.aad1329","article-title":"Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota","volume":"350","author":"V\u00e9tizou","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.03.016_bib319","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.03.016_bib320","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1158\/0008-5472.CAN-24-2232","article-title":"Mathematical Modeling and Association Analysis Decipher the Impact of the Gut Microbiome on Cancer Immunotherapy","volume":"85","author":"Hadjigeorgiou","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2026.03.016_bib321","doi-asserted-by":"crossref","first-page":"8170","DOI":"10.3390\/cimb46080483","article-title":"The Role of Estrogen across Multiple Disease Mechanisms","volume":"46","author":"Xiang","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.cell.2026.03.016_bib322","doi-asserted-by":"crossref","first-page":"10820","DOI":"10.1073\/pnas.95.18.10820","article-title":"Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor","volume":"95","author":"Jain","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2026.03.016_bib323","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41569-022-00739-0","article-title":"Mechanisms and consequences of endothelial cell senescence","volume":"20","author":"Bloom","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.cell.2026.03.016_bib324","doi-asserted-by":"crossref","first-page":"65429","DOI":"10.18632\/oncotarget.11748","article-title":"Tumor vessel normalization after aerobic exercise enhances chemotherapeutic efficacy","volume":"7","author":"Schadler","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cell.2026.03.016_bib325","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1339232","article-title":"Exercise intensity governs tumor control in mice with breast cancer","volume":"15","author":"Gomes-Santos","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cell.2026.03.016_bib326","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1158\/2326-6066.CIR-20-0499","article-title":"Exercise Training Improves Tumor Control by Increasing CD8+ T-Cell Infiltration via CXCR3 Signaling and Sensitizes Breast Cancer to Immune Checkpoint Blockade","volume":"9","author":"Gomes-Santos","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.cell.2026.03.016_bib329","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2006.09.6305","article-title":"Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200","volume":"25","author":"Giantonio","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cell.2026.03.016_bib330","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102017","article-title":"Bevacizumab (Avastin\u00ae) in cancer treatment: A review of 15 years of clinical experience and future outlook","volume":"86","author":"Garcia","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.cell.2026.03.016_bib327","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1158\/1078-0432.CCR-22-1366","article-title":"Molecular Mechanisms and Future Implications of VEGF\/VEGFR in Cancer Therapy","volume":"29","author":"Patel","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cell.2026.03.016_bib331","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1073\/pnas.1700340114","article-title":"Role of vascular normalization in benefit from metronomic chemotherapy","volume":"114","author":"Mpekris","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2026.03.016_bib333","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1073\/pnas.1525349113","article-title":"Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages","volume":"113","author":"Peterson","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2026.03.016_bib334","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1073\/pnas.1525360113","article-title":"Ang-2\/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival","volume":"113","author":"Kloepper","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2026.03.016_bib380","article-title":"Combined blockade of VEGF, Angiopoietin-2, and PD1 reprograms glioblastoma endothelial cells into quasi-antigen-presenting cells","author":"Amoozgar","year":"2022","journal-title":"Preprint at bioRxiv"},{"key":"10.1016\/j.cell.2026.03.016_bib335","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2522634122","article-title":"Physiologically based pharmacokinetic model for CAR-T cell delivery and efficacy in solid tumors","volume":"122","author":"Hadjigeorgiou","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2026.03.016_bib336","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/s41571-024-00886-y","article-title":"Antiangiogenic-immune-checkpoint inhibitor combinations: lessons from phase III clinical trials","volume":"21","author":"Kuo","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cell.2026.03.016_bib337","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jtho.2023.10.014","article-title":"A Phase 1b Study of Ivonescimab, a Programmed Cell Death Protein-1 and Vascular Endothelial Growth Factor Bispecific Antibody, as First- or Second-Line Therapy for Advanced or Metastatic Immunotherapy-Naive NSCLC","volume":"19","author":"Wang","year":"2024","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.cell.2026.03.016_bib338","article-title":"PD1 \u00d7 VEGF blocking bispecifics for cancer draw big backing","volume":"24","author":"Mullard","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cell.2026.03.016_bib339","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1599181","article-title":"Unlocking new horizons in oncology: ivonescimab's dual-target approach to anti-VEGF\/PD-1(L1) therapy","volume":"16","author":"Shi","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cell.2026.03.016_bib340","article-title":"Lipid-Based Nanoparticles in Cancer Therapy: Advances in Targeted Drug Delivery and Therapeutic Potential for Renal Cell Carcinoma","volume":"12","author":"Yao","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.cell.2026.03.016_bib341","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123630","article-title":"Silencing of VEGFR2 by RGD-Modified Lipid Nanoparticles Enhanced the Efficacy of Anti-PD-1 Antibody by Accelerating Vascular Normalization and Infiltration of T Cells in Tumors","volume":"12","author":"Cho","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cell.2026.03.016_bib342","article-title":"Multifunctional nanoplatforms for tumor microenvironment remodeling: Toward precision and intelligent cancer therapy","volume":"35","author":"Deng","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.cell.2026.03.016_bib343","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002151","article-title":"VEGFR-2 redirected CAR-T cells are functionally impaired by soluble VEGF-A competition for receptor binding","volume":"9","author":"Lanitis","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.cell.2026.03.016_bib344","doi-asserted-by":"crossref","DOI":"10.1158\/2326-6074.IO2025-A023","article-title":"Abstract A023: VEGF-neutralization by armored CAR-T cells remodel the tumor microenvironment and enhance antitumor efficacy against solid tumors","volume":"13","author":"Gao","year":"2025","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.cell.2026.03.016_bib345","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1158\/2326-6066.CIR-24-0876","article-title":"Secretion of a VEGF-Blocking scFv Enhances CAR T-cell Potency","volume":"13","author":"Supper","year":"2025","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.cell.2026.03.016_bib346","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.trecan.2025.08.009","article-title":"Overcoming solid-tumor barriers: armored CAR-T cell therapy","volume":"11","author":"Kwon","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.cell.2026.03.016_bib347","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1638186","article-title":"Breaking barriers: enhancing CAR-armored T cell therapy for solid tumors through microenvironment remodeling","volume":"16","author":"Andreou","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cell.2026.03.016_bib348","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708253","article-title":"Ang2 inhibitors and Tie2 activators: potential therapeutics in perioperative treatment of early stage cancer","volume":"13","author":"Khan","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib349","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/d41573-020-00166-1","article-title":"Immuno-oncology drug development forges on despite COVID-19","volume":"19","author":"Upadhaya","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cell.2026.03.016_bib350","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejim.2022.12.025","article-title":"Dual immune checkpoint inhibitors or combined with anti-VEGF agents in advanced, unresectable hepatocellular carcinoma","volume":"111","author":"Zhang","year":"2023","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib351","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.16_suppl.8595","article-title":"FDA analysis of immune checkpoint inhibitors in combination with vascular endothelial growth factor tyrosine kinase inhibitors in the second-line treatment of patients with advanced non-small cell lung cancer","volume":"42","author":"Malinou","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cell.2026.03.016_bib353","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0140-6736(24)02722-3","article-title":"Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China","volume":"405","author":"Xiong","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.cell.2026.03.016_bib354","article-title":"332P: Updated phase II efficacy and safety results of BNT327\/PM8002 combined with paclitaxel as second-line (2L) therapy in small cell lung cancer (SCLC)","volume":"20","author":"Cheng","year":"2025","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.cell.2026.03.016_bib355","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib356","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/neuonc\/noad066","article-title":"Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma","volume":"25","author":"Plotkin","year":"2023","journal-title":"Neuro. Oncol"},{"key":"10.1016\/j.cell.2026.03.016_bib357","doi-asserted-by":"crossref","first-page":"14676","DOI":"10.1073\/pnas.1512570112","article-title":"Anti-VEGF treatment improves neurological function and augments radiation response in NF2 schwannoma model","volume":"112","author":"Gao","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2026.03.016_bib358","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1056\/NEJMoa0902579","article-title":"Hearing improvement after bevacizumab in patients with neurofibromatosis type 2","volume":"361","author":"Plotkin","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib359","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ncpcardio0979","article-title":"Antiangiogenic therapy for normalization of atherosclerotic plaque vasculature: a potential strategy for plaque stabilization","volume":"4","author":"Jain","year":"2007","journal-title":"Nat. Clin. Pract., Cardiovasc. Med."},{"key":"10.1016\/j.cell.2026.03.016_bib360","first-page":"603","article-title":"Angiogenesis in rheumatoid Arthritis: Pathological characterization, pathogenic mechanisms, and nano-targeted therapeutic strategies","volume":"50","author":"Zhao","year":"2025","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.cell.2026.03.016_bib361","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.molmed.2024.07.011","article-title":"Leveraging insights from cancer to improve tuberculosis therapy","volume":"31","author":"Datta","year":"2025","journal-title":"Trends Mol. Med."}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867426002837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867426002837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T12:31:28Z","timestamp":1779539488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867426002837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":380,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0092867426002837"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2026.03.016","relation":{},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting angiogenesis: Lessons from 25 years of normalizing tumor vasculature","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2026.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}